CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 50 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $7,000 | +250.0% | 2,400 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 2,400 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -33.3% | 2,400 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 2,400 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -80.0% | 2,400 | 0.0% | 0.00% | – |
Q3 2018 | $15,000 | -42.3% | 2,400 | 0.0% | 0.00% | – |
Q2 2018 | $26,000 | 0.0% | 2,400 | 0.0% | 0.00% | – |
Q1 2018 | $26,000 | +85.7% | 2,400 | +20.0% | 0.00% | – |
Q4 2017 | $14,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,940,880 | $15,411,000 | 2.24% |
AWM Investment Company, Inc. | 682,434 | $5,418,000 | 0.51% |
NEXTHERA CAPITAL LP | 120,763 | $959,000 | 0.49% |
SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $2,382,000 | 0.47% |
Rock Springs Capital Management LP | 935,000 | $7,424,000 | 0.43% |
ACUTA CAPITAL PARTNERS, LLC | 175,000 | $1,390,000 | 0.33% |
Perceptive Advisors | 712,062 | $5,653,000 | 0.32% |
Hillhouse Capital Management | 854,900 | $6,788,000 | 0.13% |
Ausdal Financial Partners, Inc. | 11,800 | $94,000 | 0.04% |
Granite Investment Partners, LLC | 53,176 | $423,000 | 0.03% |